Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

In our study, zinc oxide (ZnO) nanoparticles (NPs) were prepared by precipitation (economically and in high quality) at a temperature range of 60°C to 80°C and at pH 8, and were then adorned with graphene (G) plates. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

The antimicrobial activity of the aqueous and ethanolic extracts of Myrtus communis, Ammi visnaga, and Equisetum arvense was investigated against Staphylococcus aureus, Escherichia coli, and Candida albicans by using the agar well diffusion method. Serial concentrations (15%, 30%, and 50%) of the extracts of each plant were tested and compared with gentamicin (10 μg) and fluconazole (25 μg). Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

An intrauterine system (IUS) is a type of contraception tool that is used in order to control fertility and prevent conception in women for a long period. The aim of this study was to assess the influence of copper- versus levonorgestrel-releasing IUSs on women’s health. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

Achillea millefolium L., a traditional medicinal plant from the Asteraceae family, is known for its anti-inflammatory, anti-ulcer, and anti-cancer properties, attributed to its rich content of phytochemicals (such as flavonoids, alkaloids, terpenes, tannins, and phenolic acids). Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

A total of 164 food samples were collected from various supermarkets and farmers in various areas of Babylon, were placed in plastic containers, and were transported to the laboratory. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

Musculoskeletal pain includes several types of discomfort associated with the skeletal system. Pharmaceutically, pridinol was developed in order to relax muscles Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

Acute decompensated heart failure (ADHF) is a leading cause of hospital admission and many factors are known to precipitate decompensation. We aimed to assess the decompensating factors of heart failure and the management of patients admitted to the emergency department (ED). Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

The emergence of anti-staphylococcal drug resistance has significantly increased, thereby making it difficult to control the life-threatening staphylococcal infections. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

The efficacy and easy access to antibiotics have led to their overuse, which allows for the development of resistance to them. This study took Babylon Governorate as a model to prove whether the above hypothesis is true or not. We aimed at exploring whether there are any restrictions for dealing with antibiotics by pharmacists in the Babylon Governorate, at identifying the distribution of pharmacies in Hillah, and at estimating the capability of the health authority to control them. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

The presence of alkaloids in Crassula ovata is a topic that is still unexplored, as there are no published studies on the matter. This study demonstrates the presence of an alkaloid compound (and its class) for the first time in Crassula ovata. Continue reading